RARE Drug Development Symposium: Developing Legal Agreements in Research Collaborations

December 15, 2020

Day 1: Learn how to navigate the complicated field of legal agreements when it comes to establishing a partnership in rare disease research. Emily Milligan of the Barth Syndrome Foundation and Dr. Imran Babar of Cydan talk about the strategies they have found to be most effective.

Day 2: Learn how to navigate the complicated field of legal agreements when it comes to establishing a partnership in rare disease research. Emily Milligan of the Barth Syndrome Foundation and Dr. Imran Babar of Cydan talk about the strategies they have found to be most effective.

Stay Connected

Facebook Twitter Instagram Youtube

RARE Drug Development Symposium: Developing Legal Agreements in Research Collaborations

Related

Lisa Kadyk & Aditi Desai from CIRM talk about being at Week in RARE

September is Newborn Screening Awareness Month

The Not-So-Friendly Skies: Flying When You Have a Rare Disease

Virtual Partnering Event: IN-PART & Global Genes/RARE-X

Why Is Collaboration Important in Rare Therapy Development and Research?

How Can Patient Organizations Be Research Ready?

How Can Patient Advocates Be Involved in Rare Therapy Development?

How Does Global Genes Support Advocates Looking to Expand Research Programs?

CEO Charlene Son Rigby Talks Drug Development and the Rare Research Roadmap

Stay Connected